Security
CLVT · CLARIVATE PLC
CLVTNYSECommon stockCurrentCIK 1764046Updated Sep 24, 2026
Name history
Clarivate Analytics PLC · through May 4, 2020
CLVT price & chart
Loading TradingView…
NYSE:CLVT on TradingView ↗About the company
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property, and Life Sciences & Healthcare. For more information, please visit clarivate.com.
In the news
Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities ↗
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers ↗
Recent filings
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
4 filing
4 filing
Show 5 more recent filings
144 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 1.01, 5.02, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 11,069,400,000Source | 11,490,200,000Source | 12,706,800,000Source | 13,944,900,000Source |
| GoodwillUSD | 1,566,700,000Source | 1,566,600,000Source | 2,023,700,000Source | 2,876,500,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 8,008,100,000Source | 8,441,200,000Source | 9,006,600,000Source | 9,437,700,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 329,200,000Source | 295,200,000Source | 370,700,000Source | 348,800,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 821,700,000Source | 798,300,000Source | 908,300,000Source | 872,100,000Source |
| Assets, CurrentUSD | 1,310,000,000Source | 1,244,600,000Source | 1,462,200,000Source | 1,395,200,000Source |
| Operating Lease, Right-of-Use AssetUSD | 46,600,000Source | 53,600,000Source | 55,200,000Source | 58,900,000Source |
| Other Assets, NoncurrentUSD | 68,100,000Source | 82,200,000Source | 60,800,000Source | 97,900,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,226,500,000Source | 6,351,200,000Source | 6,714,500,000Source | 7,132,400,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | 1,392,600,000Source | 1,392,600,000Source |
| Common Stock, Value, IssuedUSD | 12,810,600,000Source | 12,978,800,000Source | 11,740,500,000Source | 11,744,700,000Source |
| Retained Earnings (Accumulated Deficit)USD | -7,514,600,000Source | -7,313,500,000Source | -6,645,500,000Source | -5,658,900,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -453,100,000Source | -526,300,000Source | -495,300,000Source | -665,900,000Source |
| Stockholders' Equity Attributable to ParentUSD | 4,842,900,000Source | 5,139,000,000Source | 5,992,300,000Source | 6,812,500,000Source |
| Liabilities and EquityUSD | 11,069,400,000Source | 11,490,200,000Source | 12,706,800,000Source | 13,944,900,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,568,800,000Source | 1,433,500,000Source | 1,600,000,000Source | 1,559,800,000Source |
| Operating Lease, Liability, CurrentUSD | 18,400,000Source | 20,600,000Source | 24,400,000Source | 25,700,000Source |
| Accounts Payable, CurrentUSD | 150,600,000Source | 124,500,000Source | 144,100,000Source | 101,400,000Source |
| Operating Lease, Liability, NoncurrentUSD | 37,900,000Source | 53,200,000Source | 63,200,000Source | 72,900,000Source |
| Deferred Income Tax Liabilities, NetUSD | 212,100,000Source | 273,300,000Source | 249,600,000Source | 316,100,000Source |
| Other Liabilities, NoncurrentUSD | 86,200,000Source | 55,900,000Source | 41,900,000Source | 119,100,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 194,900,000Source | 224,800,000Source | 202,900,000Source | 291,900,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 757,200,000Source | 727,000,000Source | 708,300,000Source | 710,500,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 63,100,000Source | 59,900,000Source | 109,000,000Source | 93,900,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 5,000,000Source | -92,600,000Source | 25,500,000Source | 28,300,000Source |
| Increase (Decrease) in Accounts PayableUSD | 22,800,000Source | -15,000,000Source | 41,200,000Source | -24,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | -41,300,000Source | 21,700,000Source | -78,200,000Source | -65,700,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 628,500,000Source | 646,600,000Source | 744,200,000Source | 509,300,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 0Source | 32,000,000Source | 5,400,000Source | 24,800,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -263,200,000Source | -236,700,000Source | -237,400,000Source | 57,300,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 263,200,000Source | 289,100,000Source | 242,500,000Source | 202,900,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 10,400,000Source | 15,600,000Source | 20,600,000Source | 14,900,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -343,100,000Source | -470,100,000Source | -496,500,000Source | -759,200,000Source |
| Dividends paid | — | — | — | — |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 1,200,000Source | 1,400,000Source | — | — |
| Repayments of Long-term DebtUSD | 600,000,000Source | 198,100,000Source | 300,000,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 34,000,000Source | -75,500,000Source | 13,900,000Source | -230,800,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 256,300,000Source | 265,300,000Source | 273,500,000Source | 251,500,000Source |
| Income Taxes Paid, NetUSD | 42,100,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 11,800,000Source | -15,300,000Source | 3,600,000Source | -38,200,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 63,000,000Source | 60,600,000Source | 108,900,000Source | 102,200,000Source |
| Amortization of Intangible AssetsUSD | 735,300,000Source | 708,000,000Source | 685,100,000Source | 675,300,000Source |
| Deferred Other Tax Expense (Benefit)USD | -36,300,000Source | 44,100,000Source | -42,900,000Source | -8,100,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | 300,000Source |
| DepreciationUSD | 21,900,000Source | 19,000,000Source | 23,200,000Source | 35,200,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | -1,200,000Source |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on DisposalUSD | 0Source | 54,700,000Source | 0Source | — |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | 6,100,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -34,900,000Source | -4,200,000Source | -38,900,000Source | 45,400,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | 0Source | 278,500,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | 278,500,000Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | -700,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 0Source | 0Source | 49,400,000Source | — |
| GoodwillUSD | 1,566,700,000Source | 1,566,600,000Source | 2,023,700,000Source | 2,876,500,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 15,000,000Source | 540,700,000Source | 979,900,000Source | — |
| Goodwill, Impairment LossUSD | — | 465,700,000Source | 847,700,000Source | 4,449,100,000Source |
| Income Tax Expense (Benefit)USD | 7,200,000Source | 82,900,000Source | -101,300,000Source | -28,900,000Source |
| Net Income (Loss) Attributable to ParentUSD | -201,100,000Source | -636,700,000Source | -911,200,000Source | -3,960,200,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -201,100,000Source | -668,000,000Source | -986,600,000Source | -4,035,600,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | 8,600,000Source |
| Other Operating Income (Expense), NetUSD | -18,600,000Source | 51,800,000Source | 10,800,000Source | 324,800,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | 0Source | 0Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | 0Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 500,000Source | 900,000Source |
| Restructuring Costs and Asset Impairment ChargesUSD | 18,600,000Source | 540,300,000Source | 986,200,000Source | 4,478,500,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 2,455,200,000Source | 2,556,700,000Source | 2,628,800,000Source | 2,659,800,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 708,600,000Source | 727,600,000Source | 739,700,000Source | 729,900,000Source |
| Operating Income (Loss)USD | 71,500,000Source | -275,600,000Source | -734,700,000Source | -3,925,600,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -193,900,000Source | -553,800,000Source | -1,012,500,000Source | -3,989,100,000Source |
| Income Tax Expense (Benefit)USD | 7,200,000Source | 82,900,000Source | -101,300,000Source | -28,900,000Source |
| Net Income (Loss) Attributable to ParentUSD | -201,100,000Source | -636,700,000Source | -911,200,000Source | -3,960,200,000Source |
| Earnings Per Share, BasicUSD per share | -0.3Source | -0.96Source | -1.47Source | -5.97Source |
| Earnings Per Share, DilutedUSD per share | -0.3Source | -0.96Source | -1.47Source | -6.24Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 673,300,000Source | 693,600,000Source | 671,600,000Source | 676,100,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 673,300,000Source | 693,600,000Source | 671,600,000Source | 678,600,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 735,300,000Source | 708,000,000Source | 685,100,000Source | 675,300,000Source |
| Business Combination, Acquisition Related CostsUSD | 22,500,000Source | 17,900,000Source | 8,200,000Source | 14,200,000Source |
| Costs and ExpensesUSD | 2,383,700,000Source | 2,832,300,000Source | 3,363,500,000Source | 6,585,400,000Source |
| Current Income Tax Expense (Benefit)USD | 48,500,000Source | 61,200,000Source | -23,100,000Source | 36,800,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | — | 300,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | 6,100,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -34,900,000Source | -4,200,000Source | -38,900,000Source | 45,400,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 0Source | 0Source | 49,400,000Source | — |
| Goodwill, Impairment LossUSD | — | 465,700,000Source | 847,700,000Source | 4,449,100,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -123,600,000Source | -155,400,000Source | -180,100,000Source | 174,700,000Source |
| Interest ExpenseUSD | — | — | 293,700,000Source | 270,300,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -265,400,000Source | -283,400,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -201,100,000Source | -668,000,000Source | -986,600,000Source | -4,035,600,000Source |
| Other Cost and Expense, OperatingUSD | 81,300,000Source | 82,400,000Source | — | — |
| Other Operating Income (Expense), NetUSD | -18,600,000Source | 51,800,000Source | 10,800,000Source | 324,800,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | 0Source | 31,300,000Source | 75,400,000Source | 75,400,000Source |
Filing attachments
tm2521990d1_ex99-1.htm · 8-K · 2025-07-30
EX-99.1 2 tm2521990d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Clarivate Announces Maroun S. Mourad as President, Intellectual Property London, U.K. - July 30, 2025 - Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that Maroun S. Mourad will join the Company as President of the Intellectual Property (IP) segment, effective September 8, 2025. Maroun most recently served as President of the Claims Solutions division of Verisk Analytics Inc. He…
Read attachment ↗tm2516677d1_ex99-1.htm · 8-K · 2025-06-02
EX-99.1 3 tm2516677d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Clarivate Completes Refinancing of Majority of Senior Secured Notes Due 2026 London, U.K., June 2, 2025 - Clarivate Plc (NYSE: CLVT) (the “Company” or “Clarivate”), a leading global provider of transformative intelligence, announced today that it has successfully completed an incremental upsize of its term loan B credit facility. Pursuant to an amendment to the Company’s existing credit agreement dated as of October 31, 2019, the …
Read attachment ↗